{"id":7400,"date":"2019-11-12T00:00:00","date_gmt":"2019-11-11T23:00:00","guid":{"rendered":"https:\/\/idibell.cat\/blog\/2019\/11\/12\/innovation-for-value-analitza-lus-de-lbig-data-i-el-nou-poder-que-les-dades-atorguen-als-pacients\/"},"modified":"2020-05-13T19:45:47","modified_gmt":"2020-05-13T17:45:47","slug":"innovation-for-value-analitza-lus-de-lbig-data-i-el-nou-poder-que-les-dades-atorguen-als-pacients","status":"publish","type":"post","link":"https:\/\/idibell.cat\/2019\/11\/innovation-for-value-analitza-lus-de-lbig-data-i-el-nou-poder-que-les-dades-atorguen-als-pacients\/","title":{"rendered":"Innovation for value analitza l’\u00fas de l’big data i el nou poder que les dades atorguen als pacients"},"content":{"rendered":"
La jornada sobre innovaci\u00f3 sanit\u00e0ria\u00a0Innovation for value, celebrada el passat 8 de novembre a Barcelona, \u200b\u200bha analitzat les oportunitats que ofereixen els aven\u00e7os tecnol\u00f2gics en l’\u00e0mbit de la salut. La confer\u00e8ncia organitzada per l’Institut d’Investigaci\u00f3 Biom\u00e8dica de Bellvitge (IDIBELL) i la Plataforma d’Innovaci\u00f3 en Tecnologies M\u00e8diques i Sanit\u00e0ries (ITEMAS)\u00a0ha comptat amb la pres\u00e8ncia d’alguns dels l\u00edders m\u00e9s importants de l’\u00e0mbit sanitari a nivell internacional.<\/p>\n
\u00a0<\/p>\n
Durant la trobada, celebrada a l’Hospital Universitari de Bellvitge, Robert Hermann, de McKinsey & Company, va exposar la situaci\u00f3 de la biotecnologia a Europa a trav\u00e9s d’un mapa en el qual es recollien les empreses biotech en el continent, quins s\u00f3n els seus focus d’inter\u00e8s , les \u00e0rees en qu\u00e8 aquestes treballen i com s’estan duent a terme les inversions en aquest camp.<\/p>\n
\u00a0<\/p>\n
A m\u00e9s, durant la jornada, es van tractar les diferents opcions de finan\u00e7ament que t\u00e9 la investigaci\u00f3 sanit\u00e0ria tant al nostre pa\u00eds com a Europa. Pel que fa al finan\u00e7ament p\u00fablic, Jos\u00e9 Luis Romera, de el Centre per al Desenvolupament Tecnol\u00f2gic Industrial (CDTI), va recordar que en els 40 anys que porta treballant la instituci\u00f3 s’han destinat m\u00e9s de 26.000 milions d’euros per a projectes. I, en l’\u00faltim any, han finan\u00e7at m\u00e9s de 1.700 projectes, amb una despesa de 750 milions d’euros.<\/p>\n
\u00a0<\/p>\n
Pel que fa a la inversi\u00f3 privada en sanitat, alguns dels ponents van destacar que, a l’hora d’invertir, els fons de capital risc internacionals encara depenen del capital risc nacional quan volen liderar el finan\u00e7ament d’un projecte. Per aquest motiu, quan un projecte sanitari busca finan\u00e7ament privat el m\u00e9s recomanable \u00e9s localitzar una signatura de capital risc local que els permeti accedir a fons internacionals.<\/p>\n
\u00a0<\/p>\n
\u00a0<\/p>\n
Innovaci\u00f3 en el sistema de salut a trav\u00e9s de les dades.<\/p>\n
\u00a0<\/p>\n
D’altra banda, durant la confer\u00e8ncia tamb\u00e9 es va debatre sobre l’aplicaci\u00f3 de l’big data dins el sistema sanitari. Al panell, on van participar Juan Carlos S\u00e1nchez Rosat de IBM, Jordi Serrano Pons d’Universal Doctor, Francesc de Paula Rodr\u00edguez de Medtronic i Frederic Llordachs i Marques de Doctoralia, es va destacar que “un dels temes m\u00e9s importants \u00e9s el que el pacient sigui conscient que les seves dades els empoderen enfront de les empreses a l’hora de delegar-los-els, especialment\u00a0en el cas dels intermediaris d’assegurances.”<\/p>\n
\u00a0<\/p>\n
Tanmateix, la protecci\u00f3 de les dades i la seguretat en salut s\u00f3n temes delicats a l’hora d’aplicar els aven\u00e7os en tecnologia de manera que “haur\u00edem d’aprendre d’altres sectors amb problem\u00e0tiques similars, com el sistema financer”, van concloure en el panell.<\/p>\n
\u00a0<\/p>\n
\u00a0<\/p>\n
Medicina regenerativa i personalitzada.<\/p>\n
\u00a0<\/p>\n
Els aven\u00e7os en investigaci\u00f3 han perm\u00e8s desenvolupar una medicina regenerativa i personalitzada que est\u00e0 creant un nou paradigma sobre el desenvolupament de la propietat intel\u00b7lectual pel que es tracta d’una q\u00fcesti\u00f3 rendible per al sistema de salut.<\/p>\n
\u00a0<\/p>\n
\u00a0<\/p>\n
Dami\u00e1n Garc\u00eda-Olmo, que ha desenvolupat el primer medicament europeu basat en c\u00e8l\u00b7lules mare procedents de donant, aix\u00ed com Andreas Weiler de Novartis, Iain Miller de Healthcare Strategies Group i Bertil E. Lindmark de eTheRNA Immunotherapies, van analitzar la revoluci\u00f3 de les c\u00e8l\u00b7lules CAR- T, “un veritable exemple de medicina personalitzada que fa que els hospitals i les farm\u00e0cies treballin junts de manera coordinada per oferir el tractament adequat al pacient correcte”.<\/p>\n
\u00a0<\/p>\n
Innovation for value va finalitzar amb \u00e8xit la seva primera edici\u00f3 despr\u00e9s d’analitzar i debatre les noves tend\u00e8ncies dins de el sector sanitari, quina \u00e9s la seva acceptaci\u00f3 en el mercat i com afecten aquestes innovacions a la investigaci\u00f3 cient\u00edfica.<\/p>\n","protected":false},"excerpt":{"rendered":"
La jornada sobre innovaci\u00f3 sanit\u00e0ria\u00a0Innovation for value, celebrada el passat 8 de novembre a Barcelona, \u200b\u200bha analitzat les oportunitats que ofereixen els aven\u00e7os tecnol\u00f2gics en l’\u00e0mbit de la salut. La confer\u00e8ncia organitzada per l’Institut d’Investigaci\u00f3 Biom\u00e8dica de Bellvitge (IDIBELL) i la Plataforma d’Innovaci\u00f3 en Tecnologies M\u00e8diques i Sanit\u00e0ries (ITEMAS)\u00a0ha comptat amb la pres\u00e8ncia d’alguns dels […]<\/p>\n","protected":false},"author":6,"featured_media":10427,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"no-sidebar","site-content-layout":"page-builder","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"default","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[1],"tags":[161],"class_list":["post-7400","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-sin-categorizar","tag-promocio"],"publishpress_future_action":{"enabled":false,"date":"2024-12-30 05:44:21","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category"},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/posts\/7400","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/comments?post=7400"}],"version-history":[{"count":0,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/posts\/7400\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/media\/10427"}],"wp:attachment":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/media?parent=7400"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/categories?post=7400"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/tags?post=7400"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}